As expected, IL‐18 induced IFNG gene alteration has been increased dramatically in metastatic breast carcinoma (Figure 2B), which denotes the failure of IL‐18 to stop genetic alteration of IFNG in advanced breast cancer. The gene discussed is IL18; the disease is breast carcinoma.